Year after year, we are told domestic, non-discretionary spending must be cut to lower the national debt. As a result, the buying power of the National Institutes of Health is now 21 percent below a decade ago. Yet, now Congress seeks to advance a tax plan that will cost more than $1.5 trillion in unpaid deficit spending, draining all available future resources for needed federal investments in medical research. It is shortsighted to spend $25 federal dollars on health care for Americans for every dollar currently spent on finding a cure. If this tax plan is approved even fewer dollars will be available for medical research.
Scientific and medical innovation have helped to make our nation a global leader and have generated tremendous economic benefits to our local university community and our country. Eliminating tax credits for rare disease research will eliminate hope for millions of Americans that have help hope for a cure. Further, the House bill eliminates the student loan deduction and will tax graduate student tuition; crippling graduate programs — particularly in STEM fields that advance tomorrow’s biomedical innovators.
Please oppose the tax plan and vote NO on any conference agreement. I look forward to your reply.
Copyright © 2018 · All Rights Reserved · AIMBE
1400 I St NW, Suite 235 · Washington, DC 20005
202-496-9660 Email Us